TY - JOUR
T1 - The association of admission heart rate and in-hospital cardiovascular events in patients with non-ST-segment elevation acute coronary syndromes
T2 - Results from 135 164 patients in the CRUSADE quality improvement initiative
AU - Bangalore, Sripal
AU - Messerli, Franz H.
AU - Ou, Fang Shu
AU - Tamis-Holland, Jacqueline
AU - Palazzo, Angela
AU - Roe, Matthew T.
AU - Hong, Mun K.
AU - Peterson, Eric D.
N1 - Funding Information:
CRUSADE is funded by Schering-Plough Corporation. Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership provides additional funding support.
Funding Information:
S.B.: none. F.H.M.: Speakers’ Bureau-Abbott, GlaxoSmithKline, Novartis, Pfizer, AstraZeneca, Bayer, Boehringer Ingelheim, BMS, Forest, Sankyo, Sanofi. Research/Grants—GlaxoSmithKline, Pfizer, Novartis. F.-S.O.: none. J.T.-H.: none. A.P.: none. M.T.R.: speakers’ bureau for Millennium Pharmaceuticals, Inc., Bristol-Myers Squibb/sanofiaventis Pharmaceuticals Partner-ship, Schering Corporation; research grants from Millennium Pharmaceuticals, Inc., Bristol-Myers Squibb/Sanofi-Aventis Pharmaceuticals Partnership, and Schering Corporation. M.K.H.: none. E.D.P.: research support from BMS, Sanofi, Merck-Shering Plough.
PY - 2010/3
Y1 - 2010/3
N2 - Aims To evaluate the relationship between presenting heart rate (HR) and in-hospital events in patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS).Methods and resultsWe evaluated 139 194 patients with NSTE-ACS in the CRUSADE quality improvement initiative. The presenting HR was summarized as 10 beat increments. Patients with systolic BP < 90 mm Hg (4030 patients) were excluded to avoid the confounding effect of cardiogenic shock. An adjusted odds ratio (OR) was calculated using a reference OR = 1 for HR of 60-69 b.p.m. after controlling for baseline variables. Primary outcome was a composite of in-hospital events all-cause mortality, non-fatal re-infarction, and stroke. Secondary outcomes were each of these considered separately. From the cohort of 135 164 patients, 8819 (6.52) patients had a primary outcome (death/re-infarction or stroke) of which 5271 (3.90) patients died, 3578 (2.65) patients had re-infarction, and 1038 (0.77) patients had a stroke during hospitalization. The relationship between presenting HR and primary outcome, all-cause mortality, and stroke followed a 'J-shaped' curve with an increased event rate at very low and high HR even after controlling for baseline variables. However, there was no relationship between presenting HR and risk of re-infarction.ConclusionIn contrast to patients with stable CAD, in the acute setting, the relationship between presenting HR and in-hospital cardiovascular outcomes has a 'J-shaped' curve (higher event rates at very low and high HRs). These associations should be considered in ACS prognostic models.
AB - Aims To evaluate the relationship between presenting heart rate (HR) and in-hospital events in patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS).Methods and resultsWe evaluated 139 194 patients with NSTE-ACS in the CRUSADE quality improvement initiative. The presenting HR was summarized as 10 beat increments. Patients with systolic BP < 90 mm Hg (4030 patients) were excluded to avoid the confounding effect of cardiogenic shock. An adjusted odds ratio (OR) was calculated using a reference OR = 1 for HR of 60-69 b.p.m. after controlling for baseline variables. Primary outcome was a composite of in-hospital events all-cause mortality, non-fatal re-infarction, and stroke. Secondary outcomes were each of these considered separately. From the cohort of 135 164 patients, 8819 (6.52) patients had a primary outcome (death/re-infarction or stroke) of which 5271 (3.90) patients died, 3578 (2.65) patients had re-infarction, and 1038 (0.77) patients had a stroke during hospitalization. The relationship between presenting HR and primary outcome, all-cause mortality, and stroke followed a 'J-shaped' curve with an increased event rate at very low and high HR even after controlling for baseline variables. However, there was no relationship between presenting HR and risk of re-infarction.ConclusionIn contrast to patients with stable CAD, in the acute setting, the relationship between presenting HR and in-hospital cardiovascular outcomes has a 'J-shaped' curve (higher event rates at very low and high HRs). These associations should be considered in ACS prognostic models.
KW - Cardiovascular events
KW - Heart rate
KW - J-curve
UR - http://www.scopus.com/inward/record.url?scp=77749264587&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77749264587&partnerID=8YFLogxK
U2 - 10.1093/eurheartj/ehp397
DO - 10.1093/eurheartj/ehp397
M3 - Article
C2 - 19793769
AN - SCOPUS:77749264587
SN - 0195-668X
VL - 31
SP - 552
EP - 560
JO - European Heart Journal
JF - European Heart Journal
IS - 5
ER -